microRNA-21 and hypertension
X Li, Y Wei, Z Wang - Hypertension Research, 2018 - nature.com
Hypertension, a multifactorial disease, is a major risk factor for the development of stroke,
coronary artery disease, heart failure, and chronic renal failure. However, its underlying …
coronary artery disease, heart failure, and chronic renal failure. However, its underlying …
[HTML][HTML] New Insights into the Nephroprotective Potential of Lercanidipine
J Hajdys, P Fularski, K Leszto, G Majchrowicz… - International Journal of …, 2023 - mdpi.com
Kidneys are responsible for many crucial biological processes in the human body, including
maintaining the water–electrolyte balance, pH, and blood pressure (BP), along with the …
maintaining the water–electrolyte balance, pH, and blood pressure (BP), along with the …
PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease
F Fici, E Ari Bakir, E Ilkay Yüce, S Kanuncu… - High Blood Pressure & …, 2020 - Springer
Introduction Albuminuria is an early marker of kidney disease and reduction of albuminuria
translates into a decreased occurrence of cardiovascular and renal outcomes. Aims To …
translates into a decreased occurrence of cardiovascular and renal outcomes. Aims To …
All About Fixed-Dose Combination Lercanidipine/Enalapril: Ten Questions and Answers
Despite different antihypertensive drugs are available, blood pressure (BP) control is sub-
optimal in many countries 1, 2. Calcium channel blockers(CCBs), particularly …
optimal in many countries 1, 2. Calcium channel blockers(CCBs), particularly …
[HTML][HTML] Клинико-фармакологические приоритеты в выборе блокаторов ренин-ангиотензиновой системы и диуретиков у пациентов с неосложненной …
АИ Пономарева, ГГ Кетова… - Системные …, 2017 - cyberleninka.ru
В статье обсуждаются проблемы применения блокаторов ренин-ангиотензиновой
системы и диуретиков при артериальной гипертензии. Детально изучена структура и …
системы и диуретиков при артериальной гипертензии. Детально изучена структура и …
[HTML][HTML] Clinical-pharmacological priorities in the election of blockators of the renin-angiotenzine system and diuretics in patients with uncompleted hypertension
AI Ponomareva, GG Ketova… - Systemic …, 2017 - edgccjournal.org
The article discusses the problem of using ACE inhibitors and diuretics in arterial
hypertension. Analysis of the position of doctors when prescribing ACE inhibitors and …
hypertension. Analysis of the position of doctors when prescribing ACE inhibitors and …
Дигидропиридиновые блокаторы кальциевых каналов для нефропротективной терапии гипертензивных больных с хронической болезнью почек
ОБ Кузьмин, ВВ Жежа, ВВ Белянин - Нефрология, 2021 - journal.nephrolog.ru
Аннотация Амлодипин и селективные дигидропиридиновые блокаторы L-Са 2+-
каналов второго поколения при добавлении к ингибиторам АПФ или заменяющим их …
каналов второго поколения при добавлении к ингибиторам АПФ или заменяющим их …
Dihydropyridine calcium channel blockers for the renoprotective therapy of hypertensive patients with chronic kidney disease
OB Kuzmin, VV Zhezha… - Nephrology (Saint …, 2021 - journal.nephrolog.ru
Amlodipine and selective dihydropyridine Ca 2+ channels blockers of the second
generation in addition to ACE inhibitors or replacing them antagonists of AT1-angiotensin …
generation in addition to ACE inhibitors or replacing them antagonists of AT1-angiotensin …
[PDF][PDF] Drug Class Literature Scan: Diuretics
S Fletcher - 2012 - orpdl.org
Conclusions:• Seven clinical practice guidelines1-7, 17 systematic reviews8-24, and 2
randomized controlled trials (RCTs) 25, 26 identified for this update.• Thiazide-type diuretics …
randomized controlled trials (RCTs) 25, 26 identified for this update.• Thiazide-type diuretics …